Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.
Metrics to compare | ALKE | Peers Peers - average of corresponding metrics from companies closely matching ALKE: MOREPENLAB, LUPIN, JBCHEPHARM, EMCURE, ABBOTINDIA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALKEPeersSector |
---|---|---|---|---|
P/E Ratio | 27.7x | 33.6x | −0.5x | |
PEG Ratio | 1.34 | 1.01 | 0.00 | |
Price/Book | 5.0x | 5.5x | 2.6x | |
Price / LTM Sales | 4.6x | 4.5x | 3.2x | |
Upside (Analyst Target) | 1.9% | 5.4% | 41.4% | |
Fair Value Upside | Unlock | −1.8% | 6.0% | Unlock |